Icotinib Hydrochloride Cream in Healthy Adults and Psoriasis Patients
Status:
Completed
Trial end date:
2017-02-19
Target enrollment:
Participant gender:
Summary
This is a phase I study to evaluate the safety, tolerability and pharmacokinetics of Icotinib
Hydrochloride Cream in healthy adults and patients with mild to moderate psoriasis.